Last reviewed · How we verify

TIV — Competitive Intelligence Brief

TIV (TIV) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated influenza vaccine. Area: Immunology / Infectious Disease.

marketed Inactivated influenza vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

TIV (TIV) — Folia Biotech Inc.. TIV is a trivalent inactivated influenza vaccine that stimulates immune response against three strains of influenza virus.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
TIV TARGET TIV Folia Biotech Inc. marketed Inactivated influenza vaccine
Fluvirin(TIVf) Fluvirin(TIVf) Novartis marketed Inactivated influenza vaccine
Seasonal trivalent vaccine Seasonal trivalent vaccine Sinovac Biotech Co., Ltd marketed Inactivated influenza vaccine
HD-TIV HD-TIV McGill University Health Centre/Research Institute of the McGill University Health Centre marketed Inactivated influenza vaccine
Influsplit SSW® 2005/2006 Influsplit SSW® 2005/2006 GlaxoSmithKline marketed Inactivated influenza vaccine
Standard IIV4 Standard IIV4 Marshfield Clinic Research Foundation marketed Inactivated influenza vaccine
Trivalent split Inf Trivalent split Inf National Institute of Allergy and Infectious Diseases (NIAID) marketed Inactivated influenza vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated influenza vaccine class)

  1. GlaxoSmithKline · 16 drugs in this class
  2. Seqirus · 5 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 5 drugs in this class
  4. Green Cross Corporation · 4 drugs in this class
  5. Novartis · 2 drugs in this class
  6. SK Chemicals Co., Ltd. · 2 drugs in this class
  7. Sanofi · 2 drugs in this class
  8. Hospital Israelita Albert Einstein · 2 drugs in this class
  9. McGill University Health Centre/Research Institute of the McGill University Health Centre · 2 drugs in this class
  10. Il-Yang Pharm. Co., Ltd. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). TIV — Competitive Intelligence Brief. https://druglandscape.com/ci/tiv. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: